Partners Charlotte Garland and Matthew Olsen on the influx of foreign capital into New Zealand.
Law firm says while there are still deals to be done, investors have less appetite for risk.
ANALYSIS: Investment bank Barrenjoey’s entry has set the cat among the pigeons, but local advisers are still optimistic for the coming year.
Putting a spotlight on some of the largest deals done in the 2025/26 year.
The investment bank says it has never been busier after a year of big deals and big moves.
The Christchurch-based biotech company has raised a $13m seed round to help fund a pilot scale plant.
The deal gives the ASX-listed company an established presence in Southeast Asia.
Infratil-owned telco has been restructuring its EonFibre unit as a standalone business.
It has also secured a definitive licence for the rights to commercialise its Car-T cell therapy for a number of diseases.
Mark Stewart's Florenz acquired its initial cornerstone position in the natural health product firm in 2022.